Medication info
Vestidine Tablets 20 Milligrams (Famotidine)

Vestidine Tablets 20 Milligrams (Famotidine)

Prescription medicationTablet
Ingredient · strength
Famotidine›20mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Corporation
Appearance
Green round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 198600161 · Notified 1986.11.21 · Insurance code 644102110

Summary

Main use
Treatment of gastrointestinal disorders (such as ulcers and gastroesophageal reflux disease), pre-anesthetic medication, and upper gastrointestinal bleeding
Who uses it
Adults
Adult dosage
(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: Adults: Administer famotidine orally at 20mg twice daily (after breakfast and dinner or at bedtime), or 40mg once daily (at bedtime). In cases of upper gastrointestinal bleeding, treatment is usually initiated with an injectable formulation, and switched to oral administration when oral dosing becomes possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis, acute exacerbation of chronic gastritis Adults: Administer famotidine orally at 10mg twice daily (after breakfast and dinner or at bedtime), or 20mg once daily (at bedtime). Adjust the dose as appropriate according to age and symptoms. (Injection) Adults: Dissolve 20mg of famotidine in 20ml of Normal Saline Injection or Dextrose Injection, and administer slowly by intravenous injection twice daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip infusion. For upper gastrointestinal bleeding and Zollinger-Ellison syndrome, an effect is generally seen within 1 week. Switch to oral administration when oral dosing becomes possible. For preanesthetic medication, dissolve 20mg in 1-1.5ml of Sterile Water for Injection and administer intramuscularly 1 hour before induction of anesthesia, or dissolve it in 20ml of Normal Saline Injection or Dextrose Injection and administer slowly by intravenous injection 1 hour before induction of anesthesia. After reconstitution, use within 48 hours when stored at room temperature or refrigerated. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
JW Pharmaceutical Corporation

Efficacy & effects

Treatment of gastrointestinal disorders (such as ulcers and gastroesophageal reflux disease), pre-anesthetic medication, and upper gastrointestinal bleeding

  • Gastric ulcer
  • duodenal ulcer
  • anastomosis ulcer
  • upper gastrointestinal bleeding
  • acute stress ulcer
  • hemorrhagic gastritis
  • gastroesophageal reflux disease
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • acute gastritis
  • acute exacerbation of chronic gastritis
View approved original text

This medication can be administered orally or via injection and helps improve gastric and duodenal ulcers, anastomosis ulcers, and various lesions of the gastric mucosa (erosion, bleeding, redness, swelling). It is particularly effective for upper gastrointestinal bleeding and hemorrhagic gastritis caused by peptic ulcer and acute stress ulcer. It is also used to treat gastroesophageal reflux disease and Zollinger-Ellison syndrome, and shows efficacy during acute exacerbations of acute gastritis or chronic gastritis. Additionally, the injectable form is utilized for pre-anesthetic administration. This drug is used to improve the damaged state of the gastrointestinal mucosa and prevent bleeding, thereby enhancing digestive health.

Dosage and Administration

Adult dosage

(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: Adults: Administer famotidine orally at 20mg twice daily (after breakfast and dinner or at bedtime), or 40mg once daily (at bedtime). In cases of upper gastrointestinal bleeding, treatment is usually initiated with an injectable formulation, and switched to oral administration when oral dosing becomes possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis, acute exacerbation of chronic gastritis Adults: Administer famotidine orally at 10mg twice daily (after breakfast and dinner or at bedtime), or 20mg once daily (at bedtime). Adjust the dose as appropriate according to age and symptoms. (Injection) Adults: Dissolve 20mg of famotidine in 20ml of Normal Saline Injection or Dextrose Injection, and administer slowly by intravenous injection twice daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip infusion. For upper gastrointestinal bleeding and Zollinger-Ellison syndrome, an effect is generally seen within 1 week. Switch to oral administration when oral dosing becomes possible. For preanesthetic medication, dissolve 20mg in 1-1.5ml of Sterile Water for Injection and administer intramuscularly 1 hour before induction of anesthesia, or dissolve it in 20ml of Normal Saline Injection or Dextrose Injection and administer slowly by intravenous injection 1 hour before induction of anesthesia. After reconstitution, use within 48 hours when stored at room temperature or refrigerated. Adjust the dose as appropriate according to age and symptoms.

Precautions

This medication should not be used in patients with a history of allergic reactions to this drug or other similar medications. Additionally, since this drug contains lactose, it should not be administered to patients with genetic disorders that inhibit lactose digestion. Patients with a history of drug allergies or decreased kidney function should use this medication cautiously, and the dosage may need to be reduced or the interval extended as necessary. Patients with heart disease should be cautious as cardiac-related side effects may occur. Patients with impaired liver function should also use this medication with caution, as symptoms may worsen. Elderly patients may require dosage adjustment due to prolonged retention of the drug in the body resulting from decreased kidney function. During the use of this drug, serious allergic reactions, blood abnormalities, severe skin conditions, liver dysfunction, muscle damage, arrhythmias, kidney problems and other side effects may occur; if any unusual symptoms arise, consult a physician immediately. Regular blood tests and liver and kidney function tests should be performed during treatment, and alternative treatments may be considered if symptoms do not improve. Patients undergoing hemodialysis should exercise caution when taking this medication alongside certain phosphate binders, as this could affect calcium absorption. This drug may interact with some antifungal or anticancer agents, reducing effectiveness when taken together, so inform the physician accordingly. Pregnant women should use this drug only when the benefits of treatment outweigh the risks, and breastfeeding should be discontinued, as the drug may be passed into breast milk. The safety of this drug in children has not been sufficiently confirmed, so use should be decided cautiously. Finally, this drug may mask symptoms of gastric cancer, so it should be used only after confirming that gastric cancer is not present.

Side effects

  • Shock
  • hypersensitivity
  • anaphylaxis
  • dyspnea
  • generalized flushing
  • angioedema
  • facial edema
  • pharyngeal edema
  • urticaria
  • pancytopenia
Show 78 more
  • agranulocytosis
  • aplastic anemia
  • hemolytic anemia
  • thrombocytopenia
  • general malaise
  • weakness
  • subcutaneous hemorrhage
  • mucosal hemorrhage
  • fever
  • Stevens-Johnson syndrome
  • mucocutaneous syndrome
  • Riel syndrome
  • toxic epidermal necrolysis
  • liver dysfunction
  • jaundice
  • elevated AST
  • elevated ALT
  • rhabdomyolysis
  • hyperkalemia
  • myoglobinuria
  • elevated serum muscle enzymes
  • myalgia
  • QT prolongation
  • ventricular tachycardia
  • Torsades de Pointes
  • ventricular fibrillation
  • altered consciousness
  • seizures
  • generalized seizures
  • rigidity seizures
  • tonic seizures
  • myoclonic seizures
  • interstitial nephritis
  • acute renal failure
  • rash
  • urticaria
  • leukopenia
  • eosinophilia
  • constipation
  • diarrhea
  • loose stools
  • thirst
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • stomatitis
  • elevated blood pressure
  • facial flushing
  • tinnitus
  • bradycardia
  • tachycardia
  • heart block
  • bronchospasm
  • elevated ALP
  • elevated total bilirubin
  • elevated LDH
  • hepatitis
  • general malaise
  • lethargy
  • headache
  • drowsiness
  • insomnia
  • hallucinations
  • anxiety
  • excitement
  • decreased libido
  • paresthesia
  • heaviness in the head
  • reversible confusional state
  • depression
  • dizziness
  • menstrual irregularities
  • gynecomastia
  • arthralgia
  • elevated CK
  • taste disturbance
  • muscle cramps

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Green round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.